Recombinant human receptors and functional assays in the discovery of altinicline (SIB-1508Y), a novel acetylcholine-gated ion channel (nAChR) agonist

Author(s):  
Nicholas D.P. Cosford ◽  
Leo Bleicher ◽  
Jean-Michel Vernier ◽  
Laura Chavez-Noriega ◽  
Tadimeti S. Rao ◽  
...  
2015 ◽  
Vol 10 (6) ◽  
pp. 1266-1274 ◽  
Author(s):  
Ayumi Hirano-Iwata ◽  
Yutaka Ishinari ◽  
Hideaki Yamamoto ◽  
Michio Niwano

2000 ◽  
Vol 74 (2-3) ◽  
pp. 125-130 ◽  
Author(s):  
Nicholas D.P Cosford ◽  
Leo Bleicher ◽  
Jean-Michel Vernier ◽  
Laura Chavez-Noriega ◽  
Tadimeti S Rao ◽  
...  

eLife ◽  
2019 ◽  
Vol 8 ◽  
Author(s):  
Ailing Tong ◽  
John T Petroff ◽  
Fong-Fu Hsu ◽  
Philipp AM Schmidpeter ◽  
Crina M Nimigean ◽  
...  

Pentameric ligand-gated ion channels (pLGICs) are essential determinants of synaptic transmission, and are modulated by specific lipids including anionic phospholipids. The exact modulatory effect of anionic phospholipids in pLGICs and the mechanism of this effect are not well understood. Using native mass spectrometry, coarse-grained molecular dynamics simulations and functional assays, we show that the anionic phospholipid, 1-palmitoyl-2-oleoyl phosphatidylglycerol (POPG), preferentially binds to and stabilizes the pLGIC, Erwinia ligand-gated ion channel (ELIC), and decreases ELIC desensitization. Mutations of five arginines located in the interfacial regions of the transmembrane domain (TMD) reduce POPG binding, and a subset of these mutations increase ELIC desensitization. In contrast, a mutation that decreases ELIC desensitization, increases POPG binding. The results support a mechanism by which POPG stabilizes the open state of ELIC relative to the desensitized state by direct binding at specific sites.


2015 ◽  
Vol 10 (6) ◽  
pp. n/a-n/a
Author(s):  
Ayumi Hirano-Iwata ◽  
Yutaka Ishinari ◽  
Hideaki Yamamoto ◽  
Michio Niwano

2019 ◽  
Author(s):  
Ailing Tong ◽  
John T. Petroff ◽  
Fong-Fu Hsu ◽  
Philipp A. M. Schmidpeter ◽  
Crina M. Nimigean ◽  
...  

AbstractPentameric ligand-gated ion channels (pLGICs) are essential determinants of synaptic transmission, and are modulated by specific lipids including anionic phospholipids. The exact modulatory effect of anionic phospholipids in pLGICs and the mechanism of this effect are not well understood. Using native mass spectrometry, coarse-grained molecular dynamics simulations and functional assays, we show that the anionic phospholipid, 1-palmitoyl-2-oleoyl-phosphatidylglycerol (POPG), preferentially binds to and stabilizes the pLGIC, Erwinia ligand-gated ion channel (ELIC), and decreases ELIC desensitization. Mutations of five arginines located in the interfacial regions of the transmembrane domain (TMD) reduce POPG binding, and a subset of these mutations increase ELIC desensitization. In contrast, the L240A mutant known to decrease ELIC desensitization, increases POPG binding. The results support a mechanism by which POPG stabilizes the open state of ELIC relative to the desensitized state by direct binding at specific sites.


Planta Medica ◽  
2015 ◽  
Vol 81 (16) ◽  
Author(s):  
A Vasas ◽  
P Orvos ◽  
L Tálosi ◽  
P Forgo ◽  
G Pinke ◽  
...  

2005 ◽  
Vol 36 (02) ◽  
Author(s):  
CM Becker ◽  
J Brill ◽  
K Becker
Keyword(s):  

2011 ◽  
Vol 7 (2) ◽  
pp. 97 ◽  
Author(s):  
Niels Voigt ◽  
Dobromir Dobrev ◽  
◽  

Atrial fibrillation (AF) is the most common arrhythmia and is associated with substantial cardiovascular morbidity and mortality, with stroke being the most critical complication. Present drugs used for the therapy of AF (antiarrhythmics and anticoagulants) have major limitations, including incomplete efficacy, risks of life-threatening proarrhythmic events and bleeding complications. Non-pharmacological ablation procedures are efficient and apparently safe, but the very large size of the patient population allows ablation treatment of only a small number of patients. These limitations largely result from limited knowledge about the underlying mechanisms of AF and there is a hope that a better understanding of the molecular basis of AF may lead to the discovery of safer and more effective therapeutic targets. This article reviews the current knowledge about AF-related ion-channel remodelling and discusses how these alterations might affect the efficacy of antiarrhythmic drugs.


2003 ◽  
Vol 9 (1) ◽  
pp. 49-58
Author(s):  
Margit Asmild ◽  
Nicholas Oswald ◽  
Karen M. Krzywkowski ◽  
Søren Friis ◽  
Rasmus B. Jacobsen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document